Cargando…
Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models
Benefits and risks were reported for hormone therapy (HT) to prevent chronic disease, including Alzheimer’s disease (AD). While the Women’s Health Initiative (WHI) found no protective effect of HT on the cognitive function of women whose treatment was initiated far past the onset of menopause, other...
Autores principales: | Cui, Jie, Reed, Jon, Crynen, Gogce, Ait-Ghezala, Ghania, Crawford, Fiona, Shen, Yong, Li, Rena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804529/ https://www.ncbi.nlm.nih.gov/pubmed/31680862 http://dx.doi.org/10.3389/fncel.2019.00437 |
Ejemplares similares
-
Complementary proteomic approaches reveal mitochondrial dysfunction, immune and inflammatory dysregulation in a mouse model of Gulf War Illness
por: Zakirova, Zuchra, et al.
Publicado: (2017) -
A Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure
por: Zakirova, Zuchra, et al.
Publicado: (2016) -
Gulf War Agent Exposure Causes Impairment of Long-Term Memory Formation and Neuropathological Changes in a Mouse Model of Gulf War Illness
por: Zakirova, Zuchra, et al.
Publicado: (2015) -
Brain‐derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress
por: Dretsch, Michael N., et al.
Publicado: (2015) -
Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
por: Verma, Megha, et al.
Publicado: (2015)